Lundbeck loses €150m pay-for-delay appeal
30-03-2021
Lundbeck and Takeda take on Lupin over anti-depressant ANDA
23-05-2018
Sebastian Duda / Shutterstock.com
The EU General Court has backed the European Commission’s decision to fine pharma company Lundbeck and a number of generic producers.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
EU General Court, European Commission, pay-for-delay, Lundbeck, patent, appeal, citalopram, Merck, Sun Pharma
